Toxicity of Pyrithiones

References

• Adams M. D., Wedig J. H., Jordan R. L., Smith L. W., Henderson R., Borzelleca J. F. Urinary excretion and metabolism of salts of 2‐pyridinethiol‐ 1‐oxide following intravenous administration to female Yorkshire pigs. Toxicol. Appl. Pharmacol. 1976; 36: 523
   PubMed Web of Science ®Google Scholar
• Bartek M. J., Labudde J. A., Maibach H. I. Skin permeability in vivo: comparison in rat, rabbit, pig and man. J. Invest. Dermatol. 1972; 58: 114
   PubMed Web of Science ®Google Scholar
• Black J. G., Howes D., Rutherford T. Skin deposition and absorption of zinc pyrithione in laboratory animals. Actualities de Dermocosmétologie, Centre Europeen de Dermocosmétologie 69, Lyon 1975; VIII: 128
   Google Scholar
• Black J. G., Howes D., Rutherford T. Skin deposition and penetration of trichlorocarbanilide. Toxicology 1975; 3: 253
   PubMed Web of Science ®Google Scholar
• Youkilis E. G. Toxicology and pharmacology of pyridinethiones. MSc thesis, Duquesne University. 1966
   Google Scholar
• Collom W. D., Winek C. L. Percutaneous toxicity of pyridinethiones in a dimethylsulphoxide vehicle. J. Pharm. Sci. 1967; 56: 173
   Web of Science ®Google Scholar
• Cox A. J. Pyridine N‐oxides and their uses. Manuf. Chem. 1957; 28: 463
   Google Scholar
• Delahunt C. S., Stebbins R. B., Anderson J., Bailey J. The cause of blindness in dogs given hydroxypyridinethione. Toxicol. Appl. Pharmacol. 1962; 4: 286
   PubMed Web of Science ®Google Scholar
• Draize J. H. Procedures for the appraisal of the toxicity of chemicals in foods, drugs and cosmetics. VIII. Dermal toxicity. Food, Drug, Cosmetic Law J. 1955; 10: 722
   Google Scholar
• Draize J. H. Dermal toxicity in appraisal of the safety of chemicals in foods, drugs and cosmetics. Assoc. Food Drug Officials U.S. Quart. Bull. 1959; 46
   Google Scholar
• Edrissi M., Jadbabaee M. J., Dalziel J. A. W. New selective methods for spectrophotometric, gravimetric and titrimetric determinations of copper, using 1‐hydroxy‐2‐pyridinethione and 1‐hydroxy‐4‐methyl‐2‐pyridinethione reagents. Microchem. J. 1971; 16: 526
   Web of Science ®Google Scholar
• Edrissi M., Nanaie H., Barrett J. Photosensitivity and some spectral properties of 1‐hydroxy‐2‐pyridinethione and 1‐hydroxy‐4‐methyl‐2‐pyridinethione reagents. Microchem. J. 1973; 18: 59
   Web of Science ®Google Scholar
• Feldman R. J., Maibach H. I. Regional variation in percutaneous penetration of 14 cortisol in man. J. Invest. Dermatol. 1967; 48: 181
   PubMed Web of Science ®Google Scholar
• Gerstein T. Clear zinc pyrithione preparations. J. Soc. Cosmet. Chem. 1972; 23: 99
   Web of Science ®Google Scholar
• Howes D., Black J. G. Comparative percutaneous absorption of pyrithiones. Toxicology 1975; 5: 209
   PubMed Web of Science ®Google Scholar
• Howlett H. C. S., Van Abbe N. J. The action and fate of sodium pyridinethione when applied topically to the rabbit. J. Soc. Cosmet. Chem. 1975; 26: 3
   Web of Science ®Google Scholar
• Jenkins H. L., Tresise J. A. An adhesive tape stripping technique for epidermal histology. J. Soc. Cosmet. Chem. 1969; 20: 451
   Web of Science ®Google Scholar
• Jordan R. L., Borzelleca J. F. Teratogenic studies with zinc omadine in swine. Anat. Rec. 1975; 181: 388
   Google Scholar
• Kabacoff B. L., Fairchild C. M., Burnett C. Pyridinethione glucuronide as a metabolite of sodium pyridinethione. Food Cosmet. Toxicol. 1971; 9: 519
   PubMedGoogle Scholar
• Klaassen C. D. Absorption, distribution and excretion of zinc pyridinethione in rabbits. Toxicol. Appl. Pharmacol. 1976; 35: 581
   PubMed Web of Science ®Google Scholar
• Kligman A. M., Marples R. R., Lantis L. R., McGinley K. J. Appraisal of efficacy of antidandruff formulations. J. Soc. Cosmet. Chem. 1974; 25: 73
   Web of Science ®Google Scholar
• Leyden J. J., McGinley K. J., Kligman A. M. Role of microorganisms in dandruff. Arch. Dermatol. 1976; 112: 333
   PubMed Web of Science ®Google Scholar
• Min B. H., Parekh C., Golberg L., McChesney E. W. Experimental studies of sodium pyrithione. II. Urinary excretion following topical application to rats and monkeys. Food Cosmet. Toxicol. 1970; 8: 161
   PubMedGoogle Scholar
• Moe R. A., Kirpan J., Linegar C. R. Toxicology of hydroxypyridinethione. Toxicol. Appl. Pharmacol. 1960; 2: 156
   PubMed Web of Science ®Google Scholar
• Nolen G. A., Patrick L. F., Dierckman T. A. A percutaneous teratology study of zinc pyrithione in rabbits. Toxicol. Appl. Pharmacol. 1975; 31: 430
   PubMed Web of Science ®Google Scholar
• Okamoto K., Ito H., Hasegawa A., Urakubo G. Percutaneous absorption and residual amount on skin surface of zinc bis/2‐pyridylthio)‐N,N'‐dioxide. Eisei Kagaku 1967; 13: 323
   Google Scholar
• Okumura T., Hayashi S., Tokiwa F., Horin S. Absorption of zinc pyrithione on to hair and skin. Cosmet. Perf. 1975; 90: 101
   Google Scholar
• Olin Development Data, Omadine (l‐hydroxypyridine‐2‐thione) and derivatives, 0–1–865 (R)
   Google Scholar
• Olin Technical Bulletin, Zinc and sodium compounds of omadine
   Google Scholar
• Opdyke D. L., Burnett C. M., Brauer E. W. Anti‐seborrheic qualities of zinc pyrithione in a cream vehicle. II. Safety Evaluation. Food Cosmet. Toxicol. 1967; 5: 321
   PubMedGoogle Scholar
• Orentreich N. A clinical evaluation of two shampoos in the treatment of seborrheic dermatitis. J. Soc. Cosmet. Chem. 1972; 23: 189
   Web of Science ®Google Scholar
• Parran J. J., Jr. Deposition on the skin of particles of antimicrobial agents from detergent bases. J. Invest. Dermatol. 1965; 45: 86
   PubMed Web of Science ®Google Scholar
• Parekh C., Min B. H., Golberg L. Experimental studies of sodium pyridinethione. I. Percutaneous absorption in laboratory animals. Food Cosmet. Toxicol. 1970; 8: 147
   PubMedGoogle Scholar
• Priestley G. C., Savin J. A. The microbiology of dandruff. Brit. J. Dermatol. 1976; 94: 469
   PubMed Web of Science ®Google Scholar
• Rutherford T., Black J. G. The use of autoradiography to study the localisation of germicides on skin. Brit. J. Dermatol. 1969; 81(Suppl. 4)75
   Web of Science ®Google Scholar
• Segawa T., Takagi H. Bis‐(l‐hydroxy‐2(lH)‐pyridinethionate) zinc (ZnPT). Oya Hakuri 1970; 4: 883
   Google Scholar
• Shaw E., Bernstein J. N‐hydroxy‐2‐pyridinethiones and method of preparing same, U.S. Patent. 2, 686, 786, 1954
   Google Scholar
• Shaw E., Bernstein J., Losee K., Lott W. A. Analogs of aspergillic acid. IV. Substituted 2‐bromopyridine‐N‐oxides and their conversion to cyclic thiohydroxamic acids. J. Am. Chem. Soc. 1950; 72: 4362
   Web of Science ®Google Scholar
• Snyder F. H., Buehler E. V., Winek C. L. Safety evaluation of zinc 2‐pyridinethiol 1‐oxide in a shampoo formulation. Toxicol. Appl. Pharmacol. 1965; 7: 425
   PubMed Web of Science ®Google Scholar
• Snyder D. R., Gralla E. G., Wedig J. H. Preliminary neurological evaluation of generalised weakness in zinc pyrithionetreated rats. Food Cosmet. Toxicol. 1976; 15: 43
   Google Scholar
• Voss J. G. Skin sensitization by mercaptans of low molecular weight. J. Invest. Dermatol. 1958; 31: 373
   Web of Science ®Google Scholar
• Wedig J. H., Feldman R. J., Maibach H. I. Percutaneous penetration of the magnesium sulphate adduct of dipyrithione in man. Toxicol. Appl. Pharmacol. 1976; 41: 1
   Web of Science ®Google Scholar
• Wedig J. H., Goldhamer R., Henderson R. Percutaneous absorption, distribution and excretion of three ‘2–6–14C’ pyridinethiones in female Yorkshire pigs. Pharmacologist 1974; 16: 252
   Google Scholar
• Wedig J. H., Kennedy G. L., Jr., Jenkins D. H., Henderson R., Keplinger M. L. Teratologic evaluation of dermally applied zinc pyrithione on swine. Toxicol. Appl. Pharmacol. 1976; 36: 255
   PubMed Web of Science ®Google Scholar
• Winek C. L., Buehler E. V. Intravenous toxicity of zinc pyridinethione and several zinc salts. Toxicol. Appl. Pharmacol. 1966; 9: 269
   PubMed Web of Science ®Google Scholar